Dana-Farber Cancer Institute
Jennifer R. Brown, MD, PhD
The purpose of this study is to collect human Chronic Lymphocytic Leukemia tissue samples and medical information, in order to find out more about the causes and biology of chronic lymphocytic leukemia.
Chronic Lymphocytic Leukemia
The purpose of this study is to collect human Chronic Lymphocytic Leukemia tissue samples and medical information, in order to find out more about the causes and biology of chronic lymphocytic leukemia, for the potential development of more effective therapies for this disease.
| Study Type : | OBSERVATIONAL |
| Estimated Enrollment : | 2750 participants |
| Official Title : | Understanding Chronic Lymphocytic Leukemia |
| Actual Study Start Date : | 1999-09-29 |
| Estimated Primary Completion Date : | 2030-09-29 |
| Estimated Study Completion Date : | 2032-09-29 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 18 Years |
| Sexes Eligible for Study: | ALL |
| Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
Dana Farber Cancer Institute
Boston, Massachusetts, United States, 02115